Japan's Shionogi inks $1.4 billion US acquisition

The prescription drug firm buys specialised US company Sciele in the fourth Japanese outbound pharmaceutical deal in less than a year.

To continue reading, please login or register for free

Print Edition

FinanceAsia Print Edition

CONFERENCES